Leading Independent Proxy Advisory Firm ISS Recommends that
Athira Urges Shareholders to Vote “FOR” Athira’s Highly Qualified, Independent Director Nominees – Joseph Edelman, John M. Fluke, Jr. and Grant Pickering –...
Stay updated with breaking news from Grant Pickering. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Athira Urges Shareholders to Vote “FOR” Athira’s Highly Qualified, Independent Director Nominees – Joseph Edelman, John M. Fluke, Jr. and Grant Pickering –...
Urges shareholders to vote “FOR” Athira’s highly qualified, independent director nominees – Joseph Edelman, John M. Fluke, Jr. and Grant Pickering – on the...
Sends Letter to Athira’s Shareholders Seeking Replacement of CEO Dr. Mark LittonHighlights New Management and Shareholder Centric Directors Are Required to Provide Proper Oversight of ATH-1017 Clinical Trials to Maximize Likelihood of SuccessUrges ATHA Shareholders to VOTE the BLUE Proxy Card NEW YORK--(BUSINESS WIR...
Athira Pharma is circling the wagons and urging shareholders to reject investor Richard Kayne's calls for a management change.
Athira Pharma Reports Full Year 2021 Financial Results and Provides Clinical Update On track to report topline data from ACT-AD Phase 2 Alzheimer's disease study in 2Q22 ... | March 24, 2022